Staph is the President and Chief Executive Officer of George Health Enterprises. Previously, Staph was President and Chief Operating Officer of the Clinton Health Access Initiative (CHAI). Staph has close to 30 years of senior executive and board-level experience, leading, growing, and transforming global pharmaceutical, biotechnology and not-for profit organisations, from start-ups to large, complex multinationals, in both developed and emerging markets.
Prior to CHAI, Staph held several senior executive and board positions with leading pharmaceutical and biotechnology companies; including 11 years with SmithKline Beecham, living and managing businesses in French West Africa, Latin America, and Europe. Staph has substantial experience and a track record in fundraising, negotiating and closing a wide range of public and private sector agreements and partnerships, including cross border mergers and acquisitions. He is also the co-founder of LeapFrog Investments, the world’s first and largest investor in companies that insure underserved people in Africa and Asia.
Staph serves on a number of boards as an advisor, a Non-Executive Director and Chairman. He holds a First Class Honours Degree from City of London Polytechnic and an MSc (With Distinction) from London Business School.